(Q49060293)

18 February 2018

title

Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease (English)

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

4 July 2024

0 references

Imrich Blasko

1

1 reference

18 February 2018

Georg Kemmler

2

1 reference

18 February 2018

Susanne Jungwirth

3

1 reference

18 February 2018

Ildiko Wichart

4

1 reference

18 February 2018

Wolfgang Krampla

5

1 reference

18 February 2018

Silvia Weissgram

6

1 reference

18 February 2018

Kurt Jellinger

7

1 reference

18 February 2018

Karl Heinz Tragl

8

1 reference

18 February 2018

Peter Fischer

9

1 reference

18 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20808106

4 July 2024

publication date

1 November 2010

1 reference

18 February 2018

full work available at URL

http://intl-ajgp.psychiatryonline.org/cgi/content/abstract/18/11/973

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20808106

https://api.elsevier.com/content/article/PII:S1064748112603091?httpAccept=text/xml

4 July 2024

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

https://api.elsevier.com/content/article/PII:S1064748112603091?httpAccept=text/plain

4 July 2024

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

American Journal of Geriatric Psychiatry

4 July 2024

published in

1 reference

18 February 2018

volume

18

1 reference

18 February 2018

issue

11

1 reference

18 February 2018

page(s)

973-982

1 reference

18 February 2018

History of depression as a risk factor for dementia: an updated review.

cites work

1

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.

4 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Clinically defined vascular depression.

4 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Stroke and the risk of Alzheimer disease

4 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

The vascular depression subtype: evidence of internal validity

4 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Depressive symptoms, vascular risk factors, and Alzheimer's disease.

4 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging

4 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Does increased platelet release of Abeta peptide contribute to brain abnormalities in individuals with depression?

4 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Elevation in plasma Abeta42 in geriatric depression: a pilot study

4 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

The relationship between cerebrospinal fluid biomarkers and depression in elderly women

4 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly

4 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease

4 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Amyloid-associated depression: a prodromal depression of Alzheimer disease?

4 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

The Mini-Mental State Examination.

4 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Patterns of mild cognitive impairment after treatment of depression in the elderly

4 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Late-onset depression in elderly subjects from the Vienna Transdanube Aging (VITA) study.

4 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

A longitudinal community-based study of chronic illness, cognitive and physical function, and depression

4 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Vienna Transdanube Aging "VITA": study design, recruitment strategies and level of participation.

4 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability

4 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Depressive symptoms and cognitive decline in late life: a prospective epidemiological study

4 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

4 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

4 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community

4 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

VITA: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years.

4 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Conversion from subtypes of mild cognitive impairment to Alzheimer dementia

4 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

4 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease

4 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

4 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

4 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Late-onset major depression: clinical and treatment-response variability

4 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Frequency of depression after stroke: a systematic review of observational studies

4 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Serum creatinine levels correlate with plasma amyloid Beta protein

4 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Change in depressive symptoms during the prodromal phase of Alzheimer disease.

4 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

4 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

4 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

4 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Is plasma amyloid-beta a reliable biomarker for Alzheimer's disease?

4 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Answering autobiographical questions: the impact of memory and inference on surveys

4 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Effects of β-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat

4 July 2024

41

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Possible therapeutic implication of Aβ disturbances in depression

4 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.

4 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/JGP.0B013E3181DF48BE

4 July 2024

Identifiers

1 reference

18 February 2018

1 reference

18 February 2018